Immungenetics AG Company
German clinical-stage biotech developing effective treatments for neurodegeneration, mitochondrial dysfunctions, autoimmunity and ageing.
Founded Date:
2009
Headquarters:
Germany
Technology:
Data-driven Technologies
Employee Number:
11-50
Industry:
Energetic Process
Estimated Revenue:
$1M to $10M
Investor Type:
For Profit